We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Red Ginseng Is a Therapeutic Candidate for Chronic Doxorubicin-Induced Cardiomyopathy in Mice.
- Authors
Yoshikawa, Naoki; Hirata, Naoto; Kurone, Yuichiro; Ohta, Shin; Shimoeda, Sadahiko
- Abstract
Doxorubicin-induced cardiomyopathy (DICM) is associated with a poor prognosis, and effective therapeutic drug candidates have yet to be identified. Furthermore, whether basic animal models reflect the clinical pathogenesis of DICM should be carefully examined. Although the exact mechanisms underlying the development of DICM are complex and remain unclear, oxidative stress is strongly implicated as a contributing factor. Therefore, we investigated the effects of ginseng (the root of Panax ginseng: Gin), an inexpensive and safe drug with antioxidant properties. We previously conducted a meta-analysis that yielded results suggesting its efficacy in humans. However, this study did not examine the efficacy of ginseng in detail. Therefore, this study investigated the efficacy of red ginseng (steamed and dried ginseng cultivated for over six years; RGin) in a mouse model of chronic DICM to elucidate its potential therapeutic benefits. RGin prevented the decrease in left ventricular ejection fraction associated with doxorubicin (DXR) administration and prolonged survival in DBA/2 mice. In addition, RGin reduced DXR-induced cardiomyocyte damage. These findings highlight its potential as a therapeutic option for the treatment of DICM.
- Subjects
THERAPEUTIC use of ginseng; BIOLOGICAL models; LEFT heart ventricle; DRUG efficacy; VENTRICULAR ejection fraction; MYOCARDIUM; HEART cells; CARDIOMYOPATHIES; DOXORUBICIN; ANIMAL experimentation; ANTIOXIDANTS; OXIDATIVE stress; DATA analysis software; HEART physiology; GINSENG; MICE; EVALUATION
- Publication
Evidence-based Complementary & Alternative Medicine (eCAM), 2023, p1
- ISSN
1741-427X
- Publication type
Article
- DOI
10.1155/2023/4085409